Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2016 Dec 15;26(4):622–631. doi: 10.1158/1055-9965.EPI-16-0641

Figure 1.

Figure 1

Classification of CTL (CD8+ expression) and GZMB in tumor epithelium and stroma in TMA cores in two CRC patients. The following categorization was used for both biomarkers: 1 - non-detected; 2 - mild (1-10 cells per 0.28 mm2); 3 - moderate (11-29 cells per 0.28 mm2); 4 - strong infiltration (≥30 cells per 0.28 mm2).

HHS Vulnerability Disclosure